 |
Video: What is a Stock Split?
|
 |
Ekso Bionics Holdings designs, develops, and markets exoskeleton products that improve human strength, endurance and mobility. Co.'s business units are EksoHealth and EksoWorks. Co.'s products in EksoHealth include: EksoNR, which is a robotic exoskeleton used to provide physical therapy for patients with lower extremity impairment; and EksoUE, which is a wearable upper body exoskeleton that is used as a tool during rehabilitation. Co.'s products in EksoWorks include: EksoVest and the EVO, both of which support the weight of a worker's arms and tools, reducing the fatigue associated with working; and EksoZeroG, which is a tool holder that can mount on an aerial lift platform or scaffolding. According to our EKSO split history records, Ekso Bionics Holdings has had 1 split. | |
 |

Ekso Bionics Holdings (EKSO) has 1 split in our EKSO split history database. The split for EKSO took place on March 25, 2020. This was a 1 for 15 reverse split, meaning for each 15 shares of EKSO owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 66.6666666666667 share position following the split.
When a company such as Ekso Bionics Holdings conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.
Looking at the EKSO split history from start to finish, an original position size of 1000 shares would have turned into 66.6666666666667 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into Ekso Bionics Holdings shares, starting with a $10,000 purchase of EKSO, presented on a split-history-adjusted basis factoring in the complete EKSO split history.

Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
11/21/2014 |
|
End date: |
01/30/2023 |
|
Start price/share: |
$22.65 |
|
End price/share: |
$1.74 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-92.32% |
|
Average Annual Total Return: |
-26.88% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$768.19 |
|
Years: |
8.20 |
|
|
 |
Date |
Ratio |
03/25/2020 | 1 for 15 |
|
 |